SCHEMBL29638646

SCHEMBL29638646

Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1nccc2c(N)ncnc12

nearest known ligand 0.76

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
BRAF P15056 14/20 0.76
RAF1 P04049 9/20 0.76
CSF1R P07333 5/20 0.76
DDR1 Q08345 5/20 0.76
DDR2 Q16832 5/20 0.76
ARAF P10398 1/20 0.76
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ERN1 O75460 2/20 0.39
CHRNA7 P36544 2/20 0.39
EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25377149 1.00 BRAF (0.76) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399661 0.92 BRAF (0.79) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL30400360 0.92 BRAF (0.79) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638548 0.88 BRAF (0.79) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399701 0.88 BRAF (0.79) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399717 0.88 BRAF (0.75) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638634 0.88 BRAF (0.75) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25374279 0.88 BRAF (0.75) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399561 0.88 BRAF (0.75) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638652 0.88 BRAF (0.75) BRAFRAF1CSF1RDDR1DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096718-A Aryl amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-05-09 CN disclosed
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed